September 26th, 2013
Scrutinizing the PRAMI Trial of “Preventive Angioplasty”
Victor Montori, MD, MSc
Victor Montori offers his analysis of the PRAMI trial and the many ramifications of stopping an investigation early.
September 23rd, 2013
Selections from Richard Lehman’s Literature Review: September 23rd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include a randomized trial of preventive angioplasty in MI, aliskiren in patients with prehypertension, and otamixaban and ischemic events in NSTE-ACS.
March 14th, 2012
Angioplasty Pioneer Geoffrey Hartzler Dead at 65
Larry Husten, PHD
Geoffrey Hartzler, a key figure in the development of interventional cardiology in the United States, has died from cancer at the age of 65. He was one of the first cardiologists to learn the technique of percutaneous transluminal coronary angioplasty (PTCA) from its founder, Andreas Gruentzig. Hartzler then went on to perform the first angioplasty […]
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?